Anti-pathogen and toxicological effects of BEEMAR®- A natural honeybee and enhanced marine plasma product
The health needs of the world’s population in this century are changing dramatically. Unprecedented connectivity has played a major role in the rapid rise and spread of infectious diseases over the past two decades, including: The Severe Acute Respiratory Syndrome (SARS) virus, the Ebolavirus, HINI pandemic and the current COVID-19 virus. Although some countries have made progress towards establishing robust surveillance systems for emerging and re-emerging infectious diseases and vaccinating significant portions of their population, low and middle-income countries, and several other countries with fragile healthcare systems, remain vulnerable to these outbreaks that paralyze social and economic growth. Although vaccines are the hope toward ending these infectious disease outbreaks, these are not available and highly effective for most infectious agents. Even when vaccines are available, low-income countries face challenges with procurement, allocation, distribution and uptake. There is therefore the need for accessible and more effective options and natural products provide a cheaper and easily accessible option. The aim of this study is therefore to evaluate the anti-pathogen properties of a natural formulation composed of beehive components and nutrient-rich water. The study will also assess any cytotoxic effects of the product using secondary cell lines and animal models.
- To assess the in vitro anti-pathogen- killing effects of BEEMAR®against selected viral, bacterial and parasitic agents.
- To assess the in vivo anti-parasite properties of BEEMAR® in a mouse malaria model.
- To perform in vitro and in vivo toxicological assessments of BEEMAR®.